nodes	percent_of_prediction	percent_of_DWPC	metapath
Salmeterol—Pain in arm—Hydrochlorothiazide—nephrolithiasis	0.132	0.132	CcSEcCtD
Salmeterol—Shoulder pain—Hydrochlorothiazide—nephrolithiasis	0.0804	0.0804	CcSEcCtD
Salmeterol—Sleep disturbance—Hydrochlorothiazide—nephrolithiasis	0.0386	0.0386	CcSEcCtD
Salmeterol—Toothache—Hydrochlorothiazide—nephrolithiasis	0.0356	0.0356	CcSEcCtD
Salmeterol—Heartburn—Hydrochlorothiazide—nephrolithiasis	0.0315	0.0315	CcSEcCtD
Salmeterol—Musculoskeletal stiffness—Hydrochlorothiazide—nephrolithiasis	0.0241	0.0241	CcSEcCtD
Salmeterol—Bone pain—Hydrochlorothiazide—nephrolithiasis	0.0226	0.0226	CcSEcCtD
Salmeterol—Musculoskeletal pain—Hydrochlorothiazide—nephrolithiasis	0.0219	0.0219	CcSEcCtD
Salmeterol—Ventricular tachycardia—Hydrochlorothiazide—nephrolithiasis	0.0216	0.0216	CcSEcCtD
Salmeterol—Sleep disorder—Hydrochlorothiazide—nephrolithiasis	0.0182	0.0182	CcSEcCtD
Salmeterol—Swelling—Hydrochlorothiazide—nephrolithiasis	0.0178	0.0178	CcSEcCtD
Salmeterol—Gastroenteritis—Hydrochlorothiazide—nephrolithiasis	0.0177	0.0177	CcSEcCtD
Salmeterol—Nasal congestion—Hydrochlorothiazide—nephrolithiasis	0.0173	0.0173	CcSEcCtD
Salmeterol—Injury—Hydrochlorothiazide—nephrolithiasis	0.0171	0.0171	CcSEcCtD
Salmeterol—Atrial fibrillation—Hydrochlorothiazide—nephrolithiasis	0.0166	0.0166	CcSEcCtD
Salmeterol—Pain in extremity—Hydrochlorothiazide—nephrolithiasis	0.0157	0.0157	CcSEcCtD
Salmeterol—Migraine—Hydrochlorothiazide—nephrolithiasis	0.0155	0.0155	CcSEcCtD
Salmeterol—Abdominal pain upper—Hydrochlorothiazide—nephrolithiasis	0.0144	0.0144	CcSEcCtD
Salmeterol—Cramp muscle—Hydrochlorothiazide—nephrolithiasis	0.0142	0.0142	CcSEcCtD
Salmeterol—Influenza—Hydrochlorothiazide—nephrolithiasis	0.0136	0.0136	CcSEcCtD
Salmeterol—Upper respiratory tract infection—Hydrochlorothiazide—nephrolithiasis	0.0126	0.0126	CcSEcCtD
Salmeterol—Hyperglycaemia—Hydrochlorothiazide—nephrolithiasis	0.0123	0.0123	CcSEcCtD
Salmeterol—Pneumonia—Hydrochlorothiazide—nephrolithiasis	0.0122	0.0122	CcSEcCtD
Salmeterol—Urinary tract infection—Hydrochlorothiazide—nephrolithiasis	0.0118	0.0118	CcSEcCtD
Salmeterol—Conjunctivitis—Hydrochlorothiazide—nephrolithiasis	0.0118	0.0118	CcSEcCtD
Salmeterol—Epistaxis—Hydrochlorothiazide—nephrolithiasis	0.0114	0.0114	CcSEcCtD
Salmeterol—Sinusitis—Hydrochlorothiazide—nephrolithiasis	0.0114	0.0114	CcSEcCtD
Salmeterol—Rhinitis—Hydrochlorothiazide—nephrolithiasis	0.0109	0.0109	CcSEcCtD
Salmeterol—Pharyngitis—Hydrochlorothiazide—nephrolithiasis	0.0108	0.0108	CcSEcCtD
Salmeterol—Arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.00971	0.00971	CcSEcCtD
Salmeterol—Tension—Hydrochlorothiazide—nephrolithiasis	0.00929	0.00929	CcSEcCtD
Salmeterol—Nervousness—Hydrochlorothiazide—nephrolithiasis	0.00919	0.00919	CcSEcCtD
Salmeterol—Back pain—Hydrochlorothiazide—nephrolithiasis	0.00915	0.00915	CcSEcCtD
Salmeterol—Muscle spasms—Hydrochlorothiazide—nephrolithiasis	0.0091	0.0091	CcSEcCtD
Salmeterol—Tremor—Hydrochlorothiazide—nephrolithiasis	0.00887	0.00887	CcSEcCtD
Salmeterol—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.00878	0.00878	CcSEcCtD
Salmeterol—Agitation—Hydrochlorothiazide—nephrolithiasis	0.0087	0.0087	CcSEcCtD
Salmeterol—Angioedema—Hydrochlorothiazide—nephrolithiasis	0.00865	0.00865	CcSEcCtD
Salmeterol—Malaise—Hydrochlorothiazide—nephrolithiasis	0.00853	0.00853	CcSEcCtD
Salmeterol—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.00836	0.00836	CcSEcCtD
Salmeterol—Cough—Hydrochlorothiazide—nephrolithiasis	0.00826	0.00826	CcSEcCtD
Salmeterol—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.00806	0.00806	CcSEcCtD
Salmeterol—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.00806	0.00806	CcSEcCtD
Salmeterol—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.00806	0.00806	CcSEcCtD
Salmeterol—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.00803	0.00803	CcSEcCtD
Salmeterol—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.00796	0.00796	CcSEcCtD
Salmeterol—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.00788	0.00788	CcSEcCtD
Salmeterol—Oedema—Hydrochlorothiazide—nephrolithiasis	0.00772	0.00772	CcSEcCtD
Salmeterol—Anaphylactic shock—Hydrochlorothiazide—nephrolithiasis	0.00772	0.00772	CcSEcCtD
Salmeterol—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00754	0.00754	CcSEcCtD
Salmeterol—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.00704	0.00704	CcSEcCtD
Salmeterol—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.00699	0.00699	CcSEcCtD
Salmeterol—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.00694	0.00694	CcSEcCtD
Salmeterol—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.00689	0.00689	CcSEcCtD
Salmeterol—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.0068	0.0068	CcSEcCtD
Salmeterol—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.00666	0.00666	CcSEcCtD
Salmeterol—Constipation—Hydrochlorothiazide—nephrolithiasis	0.0066	0.0066	CcSEcCtD
Salmeterol—Pain—Hydrochlorothiazide—nephrolithiasis	0.0066	0.0066	CcSEcCtD
Salmeterol—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.00636	0.00636	CcSEcCtD
Salmeterol—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.00632	0.00632	CcSEcCtD
Salmeterol—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.00614	0.00614	CcSEcCtD
Salmeterol—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.00611	0.00611	CcSEcCtD
Salmeterol—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00611	0.00611	CcSEcCtD
Salmeterol—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.00569	0.00569	CcSEcCtD
Salmeterol—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00554	0.00554	CcSEcCtD
Salmeterol—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00528	0.00528	CcSEcCtD
Salmeterol—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00511	0.00511	CcSEcCtD
Salmeterol—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00491	0.00491	CcSEcCtD
Salmeterol—Rash—Hydrochlorothiazide—nephrolithiasis	0.00487	0.00487	CcSEcCtD
Salmeterol—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00487	0.00487	CcSEcCtD
Salmeterol—Headache—Hydrochlorothiazide—nephrolithiasis	0.00484	0.00484	CcSEcCtD
Salmeterol—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00459	0.00459	CcSEcCtD
